Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Post Injection Inflammation and Pain After Ranibizumab vs Aflibercept Intravitreal Injections

NCT01926977 is registered in ClinicalTrials.gov with Arshad Khanani as lead sponsor.

NCT NCT01926977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Post Injection Inflammation and Pain After Ranibizumab vs Aflibercept Intravitreal Injections
Lead sponsor
Arshad Khanani
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2013
Completion date
May 31, 2014
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration